GKZ: Counter, Differential Cell

Product code GKZ, “Counter, Differential Cell” in FDA's classification database, is a Class II device type under 21 CFR 864.5220 (automated differential cell counter), reviewed by FDA's Hematology panel. FDA's 510(k) database lists 381 clearances under GKZ, 47 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
GKZ
Regulation
21 CFR 864.5220
Class
II
Panel
Hematology
Clearances
381
Most recent
Sep 14, 2026
Median review, last 2 years
214 days
Third-party review
Not eligible
Implant
No

What it covers

An automated differential cell counter is a device used to identify one or more of the formed elements of the blood. The device may also have the capability to flag, count, or classify immature or abnormal hematopoietic cells of the blood, bone marrow, or other body fluids. These devices may combine an electronic particle counting method, optical method, or a flow cytometric method utilizing monoclonal CD (cluster designation) markers. The device includes accessory CD markers.

The identification in 21 CFR 864.5220, automated differential cell counter. FDA gives GKZ no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K260781Yumizen H550HORIBA ABX SASSep 14, 2026Traditional
K253212XR-Series (XR-10, XR-20) Automated Hematology AnalyzersSysmex America, Inc.May 27, 2026Traditional
K243348Athelas HomeAthelas, Inc.Feb 6, 2026Traditional
K251249Tru Hematology TestTruvian Sciences, Inc.Jan 16, 2026Traditional
K250943Sysmex XR-Series (XR-10) Automated Hematology AnalyzerSysmex America, Inc.Jun 25, 2025Traditional
K251371Sysmex XR-Series (XR-20) Automated Hematology AnalyzerSysmex America, Inc.Jun 25, 2025Traditional
K243283Alinity h-series SystemAbbott LaboratoriesFeb 20, 2025Traditional
K240402Cito CBC SystemCytochip, Inc.Feb 3, 2025Dual Track
K240252UniCel DxH 900 Coulter Cellular Analysis System; UniCel DxH Slidemaker Stainer II Coulter Cellular Analysis System; UniCel DxH 690T Coulter Cellular Analysis SystemBeckman Coulter, Inc.Jul 5, 2024Traditional
K232946Yumizen H2500HORIBA ABX SASMay 21, 2024Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 381 with a free account)

Clearances by year

47 GKZ 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)4254
20254108
20243157
20234329
20223638
20201156
20195210
20183270
20174280
20163198
20153273
20143165
20131373
20123408
20113315

Who submits

19 applicants cleared a GKZ device since 2011. 72% of the clearances went to applicants in United States, then France (11%), Israel (11%) and China (4%). By type: Traditional 83%, Abbreviated 6%, Dual Track 6% and Special 4%.

ApplicantClearances since 2011
Sysmex America, Inc.11
HORIBA ABX SAS5
Abbott Laboratories4
Beckman Coulter, Inc.4
Athelas, Inc.3
Beckman Coulter3
Diatron U.S., Inc.2
Mindray Bio-Medical Electronics Co., Ltd.2

How FDA classifies it

Class II (special controls). The special control for this device is the FDA document entitled “Class II Special Controls Guidance Document: Premarket Notifications for Automated Differential Cell Counters for Immature or Abnormal Blood Cells; Final Guidance for Industry and FDA.”

From 21 CFR 864.5220. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 864.5220 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent GKZ clearances declared.

Ask about GKZ

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about GKZ

What is FDA product code GKZ?

Product code GKZ, “Counter, Differential Cell” in FDA's classification database, is a Class II device type under 21 CFR 864.5220 (automated differential cell counter), reviewed by FDA's Hematology panel. FDA's 510(k) database lists 381 clearances under GKZ, 47 of them since 2011.

How many 510(k) clearances are there under GKZ?

FDA’s 510(k) database listed 381 clearances under GKZ as of Oct 29, 2026, 47 of them decided since 2011; the most recent decision was Sep 14, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a GKZ 510(k)?

For the 8 GKZ clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 214 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most GKZ clearances?

Since 2011: Sysmex America, Inc. (11), HORIBA ABX SAS (5), Abbott Laboratories (4), Beckman Coulter, Inc. (4) and Athelas, Inc. (3). 19 applicants have cleared a GKZ device in that time.

Sources

  1. FDA product classification: GKZ · Product Classification database
  2. 21 CFR 864.5220: Automated differential cell counter · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for GKZ · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow GKZGet an email when FDA clears, recalls or publishes guidance for GKZ devices.

Know what FDA already cleared.